Claritev Corp
NYSE:CTEV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tenable Holdings Inc
NASDAQ:TENB
|
US |
Claritev Corp
Capital Expenditures
Claritev Corp
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Claritev Corp
NYSE:CTEV
|
Capital Expenditures
-$129.6m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Capital Expenditures
-$29.1m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-3%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Capital Expenditures
-$38.5m
|
CAGR 3-Years
-62%
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Capital Expenditures
-$6.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Capital Expenditures
-$60.4m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-12%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Capital Expenditures
-$26.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Claritev Corp
Glance View
Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.
See Also
What is Claritev Corp's Capital Expenditures?
Capital Expenditures
-129.6m
USD
Based on the financial report for Dec 31, 2025, Claritev Corp's Capital Expenditures amounts to -129.6m USD.
What is Claritev Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-13%
Over the last year, the Capital Expenditures growth was -10%. The average annual Capital Expenditures growth rates for Claritev Corp have been -13% over the past three years , -13% over the past five years .